- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01820598
Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients (StimobII)
Acute and Medium-term Effects of Neuromuscular Electrical Multisite System (Kneehab®) on Cardiovascular Parameters and Induced Muscle Fatigue in Morbidly Obese Patients: Comparison With the Unidirectional Standard Device
The study was designed to test the following hypotheses:
In patients with severe obesity, a multisite electrostimulation session (m-NMES) will induce higher changes in metabolic, inflammatory and cardiovascular parameters and higher increase in muscle strength during stimulated contractions than conventional unidirectional electrostimulation session (c-NMES).
In patients with severe obesity, a six-weeks m-NMES training program will enhance cardiovascular, metabolic and inflammatory parameters.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Background: Physical activity is known to reduce cardiovascular risk as far as even minor change in lifestyle could occur. In obesity, physical activity programs remain challenging due to multifactorial causes related to body mass such as shortness of breath, traumatological pain or psychosocial causes. Although neuromuscular electrical stimulation training is presently ignored in the management of obesity, this technique may be appropriate and useful for muscle deconditioning in these patients. Furthermore, direct effects of electrostimulation training program on vascular function have been previously reported in spinal cord injury and chronic heart disease, suggesting that improvement in cardiovascular function may be expected. While a promising new technique of multisite electrical stimulation (the Kneehab® system) has been recently commercialized, few study have investigated the acute effects of electrostimulation on vascular function and not any study report the effects of electrical stimulation in obese patients.
MAIN OUTCOME OF THE ACUTE PHASE STUDY (1st part):To study the effect of multisite electrical stimulation session (m-NMES) on arterial stiffness as compared to conventional unidirectional electrical stimulation session (c-NMES) in patients with severe obesity. Secondary outcomes of the observational study: 1/ To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as electrically-induced muscle fatigue as compared with c-NMES in patients with morbid obesity. 2/ To study the profile of responders to electrical stimulation according to body composition, 6-minute walking distance, spontaneous physical activity or susceptibility to tolerate electrical stimulation. Response to electrical stimulation will be assessed by an improvement in arterial stiffness after stimulation, if so.
MAIN OUTCOME OF THE INTERVENTIONAL STUDY (2nd part):To study the effect of a multisite electrical stimulation training program (m-NMES) (6 weeks, 30 sessions) on arterial stiffness in patients with severe obesity. Secondary outcomes of the interventional study: To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as muscle strength, body composition, functional capacity (6-minute walking distance) and spontaneous physical activity, after 15 sessions (3 weeks) and after 30 sessions (6 weeks) of training program. Evaluation of the dose-response to m-NMES training in terms of arterial stiffness and functional capacity.
Expected outcomes: Acute change in arterial stiffness and/or endothelial function is expected after one m-NMES session and/or after c-NMES session. M-NMES session is expected to induce higher changes than c-NMES stimulation session on cardiovascular and muscle parameters. Chronic changes in arterial stiffness and/or endothelial function is expected after 6 weeks of m-NMES training.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Grenoble, Frankrig
- Rekruttering
- Hopital Universitaire
-
Kontakt:
- Jean-Louis Pepin, MD, PhD
- Telefonnummer: 0476765516
- E-mail: JPepin@chu-grenoble.fr
-
Kontakt:
- Isabelle, Vivodtzev, PhD
- Telefonnummer: 0476510304
- E-mail: i.vivodtzev@agiradom.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or female, aged over 18 years
- Morbid obesity (BMI > 35 kg/m²)
- Not included into exercise training program in the year prior to inclusion- Spontaneous physical activity lower than 160 min wk (i.e. < 30 min/d x 5 d/wk).
Additional Inclusion criteria for the interventional study:
- Patients with PWV > 9.3 m / s
Exclusion Criteria:
- Underage- Pregnant or parturient women
- Persons deprived of their liberty for judicial or administrative reasons, person under a legal protection measure (article L1121-8)
- Exclusion period in other studies- Person not affiliated to a social security scheme
- Chronic alcoholism
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: m-NMES first
Multisite electrostimulator first (Visit 1) and conventional electrostimulator then (Visit 2)
|
Andre navne:
|
|
Andet: c-NMES first
Conventional electrostimulator first (Visit 1) and multisite electrostimulator then (Visit 2)
|
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Delta arterial stiffness
Tidsramme: Day1 and Day3
|
Change in carotid-femoral Pulse wave velocity (PWV) after NMES sessions
|
Day1 and Day3
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Delta pulse arterial tonus (RH-PAT)
Tidsramme: Day1 and Day3
|
change in pulse arterial tonometry after NMES sessions
|
Day1 and Day3
|
|
NMES-induced muscle fatigue
Tidsramme: Day1 and Day3
|
change in maximal voluntary contraction after NMES sessions
|
Day1 and Day3
|
|
Delta blood pressure
Tidsramme: Day1 and Day3
|
changes in systolic and diastolic blood pressures after NMES sessions
|
Day1 and Day3
|
|
Delta plasmatic biomarkers
Tidsramme: Day1 and Day3
|
changes in inflammatory and metabolic plasmatic biomarkers after NMES sessions
|
Day1 and Day3
|
|
Body composition
Tidsramme: Day1, Day21 and Day 42
|
Fat-free mass and fat-free mass indexes assessed by impedancemetry
|
Day1, Day21 and Day 42
|
|
Spontaneous physical activity
Tidsramme: Day1 and Day 42
|
Number of hours per day of physical activity at 1, 2, 3, 4 or 5 metabolic equivalent(METS),Number of step per day,using a 7-days actigraphy
|
Day1 and Day 42
|
|
Maximal voluntary contraction
Tidsramme: Day1, Day21 and Day 42
|
Quadriceps peak force
|
Day1, Day21 and Day 42
|
|
Walking distance
Tidsramme: Day1 and Day 42
|
6-minute-walking test
|
Day1 and Day 42
|
|
Arterial stiffness
Tidsramme: Day1, Day21 and Day 42
|
Pulse wave velocity (PWV) measurements
|
Day1, Day21 and Day 42
|
|
Pulse artery tone (RH-PAT)
Tidsramme: Day1, Day21 and Day 42
|
Pulse artery tonometry measurement
|
Day1, Day21 and Day 42
|
|
Plasmatic biomarkers
Tidsramme: Day1, Day21 and Day 42
|
Inflammatory and metabolic biomarkers
|
Day1, Day21 and Day 42
|
|
Blood pressure
Tidsramme: Day1, Day21 and Day 42
|
Arterial systolic and diastolic blood pressure
|
Day1, Day21 and Day 42
|
|
Response to m-NMES
Tidsramme: Day42
|
Delta in current intensity during m-NMES between the first to the last session
|
Day42
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Jean-Louis Pépin, MD, PhD, Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 12-AGIR-04
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .